Rapid Medical™, a leading developer of advanced endovascular devices, has announced the successful completion of the first U.S. procedures using its breakthrough deflectable access platform, DRIVEWIRE 24. This debut took place at the 2024 Society of NeuroInterventional Surgery’s (SNIS) 21st Annual Meeting. DRIVEWIRE 24 features active technology that allows for the articulation of a wide range of catheters, providing direct access to various endovascular locations.
Dr. Shahram Majidi of Mount Sinai Health System in New York City highlighted the significance of this innovation, stating, "DRIVEWIRE addresses a major unmet need in the endovascular space. It transforms access across a range of procedures, from aneurysms to strokes and more. My first experience with DRIVEWIRE suggests it could make procedures faster, safer, and less expensive." During the initial procedures, DRIVEWIRE 24 successfully navigated an aspiration catheter to an M2 arterial occlusion for excellent reperfusion on the first pass and maneuvered complex turns to place flow diverters in a multilobed aneurysm.
The DRIVEWIRE 24 platform provides high-performance intravascular steering, enabling physicians to control the guidewire tip's direction and shape in real-time without the need for wire removal for reshaping. It also features variable support to articulate a wide range of micro and intermediate catheters, eliminating the need for advanced forerun or additional support devices. This precision navigation enhances the efficiency and safety of neuro and peripheral vascular procedures. Giora Kornblau, Chief Technology Officer at Rapid Medical, emphasized the goal of the new technology: "With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires. We want Rapid to be the first place physicians look when seeking technologies that increase clinical possibilities and patient safety."
Click here to read the original news story.